Comparison of 99mTc-labeled PR81 and its F(ab0)2 fragments as radioimmunoscintigraphy agents for breast cancer imaging

Annals of Nuclear Medicine

Volumn 25, Issue 2, 2011, Pages 87-92

  Salouti, Mojtaba ^d   Babaei, Mohammad Hossein ^a   Rajabi, Hossein ^b   Foroutan, Haleh ^a   Rasaee, Mohammad Javad ^b   Rajabi, Ahmad Bitarafan ^c   Mohammadnejad, Javad ^b   Shafiee, Mohammad ^a   Mazidi, Mohammad ^a   Daha, Fariba Johari ^a  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NONE

Author keywords

99mTc labeling; Breast cancer; F(ab')2 fragment; Imaging; Monoclonal antibody PR81

Indexed keywords

IMMUNOGLOBULIN F(AB')2 FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PR81; PEPSIN A; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER SCINTISCANNING; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; IMMUNOREACTIVITY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RADIOISOTOPE DISTRIBUTION; SENSITIVITY AND SPECIFICITY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; ORGANOTECHNETIUM COMPOUNDS; PEPSIN A; RADIOIMMUNODETECTION;

EID: 79954429826     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0434-2     Document Type: Article

References (16)

1. Al-Ejeh F, Darby JM, Thierry B, Brown MP. A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution. Nucl Med Biol. 2009; 36:395-402.
2. Burvenich IJ, Schoonooghe S, Blanckaert P, Bacher K, Vervoort L, Coene E, et al. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab0)(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor. Nucl Med Biol. 2007;34:257-65. (Pubitemid 46441854)
3. Salouti M, Rajabi H, Babaei MH, Rasaee MJ. Breast tumor targeting with (99m) Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical. Nucl Med Biol. 2008;35:763-8.
4. Lamoyi E, Nisonoff A. Preparation of F(ab0)2 fragments from mouse IgG of various subclasses. J Immunol Methods. 1983; 56:235-43. (Pubitemid 13183967)
5. Abrams MJ, Juweid M, Tenkate CI. Technetium-99m human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med. 1990;31:2022-8.
6. Larsen SK, Caldwell G, Higgins JD, Abram MS, Solomon HF. Technetium complex of tricine: useful precursor for the 99mTc labelling of hydrazino nicotinamide modified proteins. J Label Compd Radiopharm. 1994;35:1-2. (Pubitemid 24159241)
7. Mather SJ, Ellison D. Reduction mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med. 1990;31:692-7. (Pubitemid 20179715)
8. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PAJ. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods. 1984;72:77-89. (Pubitemid 14091996)
9. Pieve CD, Perkins AC, Missailidis S. Anti-MUC1 aptamers: radiolabelling with (99m)Tc and biodistribution in MCF-7 tumour-bearing mice. Nucl Med Biol. 2009;36:703-10.
10. Schuhmacher J, Klivényi G, Kaul S, Henze M, Matys R, Hauser H, et al. Pretargeting of human mammary carcinoma xenografts with bispecific anti-MUC1/anti-Ga chelate antibodies and immunoscintigraphy with PET. Nucl Med Biol. 2001;28:821-8. (Pubitemid 32900640)
11. Baum RP, Brümmendorf TH. Radioimmunolocalization of primary and metastatic breast cancer. Q J Nucl Med. 1998;42: 33-42. (Pubitemid 28244265)
12. Albrecht H, Denardo GL, Denardo SL. Development of anti- MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers. Q J Nucl Med Mol Imaging. 2007;51:304-13. (Pubitemid 350267701)
13. Boswell CA, Brechbiel MW. Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. Nucl Med Biol. 2007;34:757-78. (Pubitemid 47503817)
14. Pietersz GA, Wenjun L, Krauer K, Baker T, Wreschner D, McKenzie IF. Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy. Cancer Immunol Immunother. 1997;44:323-8. (Pubitemid 27364612)
15. Fass L. Imaging and cancer: a review. Mol Oncol. 2008;2: 115-52.
16. Oldham RK, Dillman RO. Monoclonal antibodies in cancer therapy: 25 years of progress. J Clin Oncol. 2008;26:1774-7.